{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:14:58Z","timestamp":1790118898617,"version":"4.0.1"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1093\/brain\/awu367","type":"journal-article","created":{"date-parts":[[2014,12,26]],"date-time":"2014-12-26T01:12:10Z","timestamp":1419556330000},"page":"772-783","source":"Crossref","is-referenced-by-count":227,"title":["Independent information from cerebrospinal fluid amyloid-\u03b2 and florbetapir imaging in Alzheimer's disease"],"prefix":"10.1093","volume":"138","author":[{"given":"Niklas","family":"Mattsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Insel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Jagust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Q.","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,24]]},"reference":[{"key":"key\n\t\t\t\t20170425180355_awu367-B1","doi-asserted-by":"crossref","first-page":"270\u20139","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"key\n\t\t\t\t20170425180355_awu367-B2","doi-asserted-by":"crossref","first-page":"543\u201352","DOI":"10.1177\/1352458512460603","article-title":"Cerebrospinal fluid biomarkers of \u03b2-amyloid metabolism in multiple sclerosis","volume":"19","author":"Augutis","year":"2013","journal-title":"Mult Scler"},{"key":"key\n\t\t\t\t20170425180355_awu367-B3","volume-title":"lme4: Mixed-effects modeling with R","author":"Bates","year":"2010"},{"key":"key\n\t\t\t\t20170425180355_awu367-B4","doi-asserted-by":"crossref","first-page":"605\u201313","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B5","doi-asserted-by":"crossref","first-page":"131\u201344","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B6","volume-title":"Model Selection and Multimodal Inference","author":"Burnham","year":"2002","edition":"2 edn"},{"key":"key\n\t\t\t\t20170425180355_awu367-B7","doi-asserted-by":"crossref","first-page":"1557\u201362","DOI":"10.1001\/archneurol.2009.279","article-title":"Absence of PIttsburgh compound B detection of cerebralamyloid beta in a patient with clinical, cognitive, and cerebrospinal fluidmarkers of alzheimer disease","volume":"66","author":"Cairns","year":"2009","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B8","first-page":"275\u201383","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170425180355_awu367-B9","doi-asserted-by":"crossref","first-page":"949\u201356","DOI":"10.1001\/archneurol.2010.179","article-title":"Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people","volume":"67","author":"De Meyer","year":"2010","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B10","doi-asserted-by":"crossref","first-page":"614\u201329","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B11","doi-asserted-by":"crossref","first-page":"512\u20139","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B12","doi-asserted-by":"crossref","first-page":"371\u201380","DOI":"10.1002\/emmm.200900048","article-title":"Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease","volume":"1","author":"Fagan","year":"2009","journal-title":"EMBO Mol Med"},{"key":"key\n\t\t\t\t20170425180355_awu367-B13","doi-asserted-by":"crossref","first-page":"341\u201355","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170425180355_awu367-B14","doi-asserted-by":"crossref","first-page":"11\u201322","DOI":"10.1093\/cercor\/bhg087","article-title":"Automatically parcellating the human cerebral cortex","volume":"14","author":"Fischl","year":"2004","journal-title":"Cereb Cortex"},{"key":"key\n\t\t\t\t20170425180355_awu367-B15","doi-asserted-by":"crossref","first-page":"1456\u201365","DOI":"10.1016\/j.neurobiolaging.2007.03.029","article-title":"PET imaging of amyloid deposition in patients with mild cognitive impairment","volume":"29","author":"Forsberg","year":"2008","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20170425180355_awu367-B16","volume-title":"The elements of statistical learning","author":"Friedman","year":"2009"},{"key":"key\n\t\t\t\t20170425180355_awu367-B17","doi-asserted-by":"crossref","first-page":"927\u201334","DOI":"10.1016\/j.biopsych.2009.01.027","article-title":"Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid","volume":"65","author":"Grimmer","year":"2009","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t20170425180355_awu367-B18","doi-asserted-by":"crossref","first-page":"316\u201320","DOI":"10.1159\/000100926","article-title":"Prediction of Alzheimer's disease using the CSF Abeta42\/Abeta40 ratio in patients with mild cognitive impairment","volume":"23","author":"Hansson","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"key\n\t\t\t\t20170425180355_awu367-B19","doi-asserted-by":"crossref","first-page":"353\u20136","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"key\n\t\t\t\t20170425180355_awu367-B20","doi-asserted-by":"crossref","first-page":"1630\u201345","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170425180355_awu367-B21","doi-asserted-by":"crossref","first-page":"18190\u20139","DOI":"10.1523\/JNEUROSCI.1592-13.2013","article-title":"Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain","volume":"33","author":"Iliff","year":"2013","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170425180355_awu367-B22","doi-asserted-by":"crossref","first-page":"685\u201391","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J Magn Reson Imaging"},{"key":"key\n\t\t\t\t20170425180355_awu367-B23","doi-asserted-by":"crossref","first-page":"378\u2013384","DOI":"10.2967\/jnumed.111.090340","article-title":"Performance characteristics of amyloid PET with florbetapir F 18 in patients with Alzheimer's disease and cognitively normal subjects","volume":"53","author":"Joshi","year":"2012","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20170425180355_awu367-B24","doi-asserted-by":"crossref","first-page":"306\u201319","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B25","doi-asserted-by":"crossref","first-page":"378\u201383","DOI":"10.1159\/000163927","article-title":"PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment","volume":"26","author":"Koivunen","year":"2008","journal-title":"Dementia and Geriatr Cogn Disord"},{"key":"key\n\t\t\t\t20170425180355_awu367-B26","doi-asserted-by":"crossref","first-page":"441\u201351","DOI":"10.3233\/JAD-132489","article-title":"Qualification of a surrogate matrix-based absolute quantification method for amyloid-\u03b242in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry","volume":"41","author":"Korecka","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"key\n\t\t\t\t20170425180355_awu367-B27","doi-asserted-by":"crossref","first-page":"1207\u201318","DOI":"10.1016\/j.neurobiolaging.2009.07.002","article-title":"Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI","volume":"32","author":"Landau","year":"2011","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20170425180355_awu367-B28","doi-asserted-by":"crossref","first-page":"826\u201336","DOI":"10.1002\/ana.23908","article-title":"Comparing positron emission tomography imaging and cerebrospinal fluid measurements of \u03b2-amyloid","volume":"74","author":"Landau","year":"2013","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B29","doi-asserted-by":"crossref","first-page":"578\u201386","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"Landau","year":"2012","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B30","doi-asserted-by":"crossref","first-page":"987\u201394","DOI":"10.1373\/clinchem.2013.220392","article-title":"Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-\u03b2 in cerebrospinal fluid","volume":"60","author":"Leinenbach","year":"2014","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20170425180355_awu367-B31","doi-asserted-by":"crossref","DOI":"10.1002\/9781119013563","volume-title":"Statistical analysis with missing data","author":"Little","year":"2002","edition":"2 edn"},{"key":"key\n\t\t\t\t20170425180355_awu367-B32","doi-asserted-by":"crossref","first-page":"386\u201395, e6","DOI":"10.1016\/j.jalz.2011.05.2243","article-title":"The Alzheimer's association external quality control program for cerebrospinal fluid biomarkers","volume":"7","author":"Mattsson","year":"2011","journal-title":"Alzheimers Dement"},{"key":"key\n\t\t\t\t20170425180355_awu367-B33","doi-asserted-by":"crossref","first-page":"251\u2013261","DOI":"10.1016\/j.jalz.2013.01.010","article-title":"CSF biomarker variability in the Alzheimer's Association quality control program","volume":"9","author":"Mattsson","year":"2013","journal-title":"Alzheimers Dement"},{"key":"key\n\t\t\t\t20170425180355_awu367-B34","doi-asserted-by":"crossref","first-page":"448\u201354","DOI":"10.1177\/1352458508100031","article-title":"Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis","volume":"15","author":"Mattsson","year":"2009","journal-title":"Mult Scler"},{"key":"key\n\t\t\t\t20170425180355_awu367-B35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2377-10-51","article-title":"Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism","volume":"10","author":"Mattsson","year":"2010","journal-title":"BMC Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B36","doi-asserted-by":"crossref","first-page":"534\u201343","DOI":"10.1002\/acn3.81","article-title":"Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease","volume":"1","author":"Mattsson","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B37","doi-asserted-by":"crossref","first-page":"e31084","DOI":"10.1371\/journal.pone.0031084","article-title":"BACE1 Inhibition induces a specific cerebrospinal fluid beta-amyloid pattern that identifies drug effects in the central nervous system","volume":"7","author":"Mattsson","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170425180355_awu367-B38","doi-asserted-by":"crossref","first-page":"1550\u201361","DOI":"10.1093\/brain\/awu043","article-title":"Association of brain amyloid-\u03b2 with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment","volume":"137","author":"Mattsson","year":"2014","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170425180355_awu367-B39","doi-asserted-by":"crossref","first-page":"16507\u201316","DOI":"10.1523\/JNEUROSCI.3647-11.2011","article-title":"Robust central reduction of amyloid-\u03b2 in humans with an orally available, non-peptidic \u03b2-secretase inhibitor","volume":"31","author":"May","year":"2011","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170425180355_awu367-B40","doi-asserted-by":"crossref","first-page":"263\u20139","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"key\n\t\t\t\t20170425180355_awu367-B41","doi-asserted-by":"crossref","first-page":"336\u201345","DOI":"10.1373\/clinchem.2004.039347","article-title":"Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology","volume":"51","author":"Olsson","year":"2005","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t20170425180355_awu367-B42","doi-asserted-by":"crossref","first-page":"1282\u20131289","DOI":"10.1001\/jamaneurol.2014.1358","article-title":"Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid \u03b2-Amyloid 42: a cross-validation study against amyloid positron emission tomography","volume":"71","author":"Palmqvist","year":"2014","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B43","doi-asserted-by":"crossref","first-page":"189ra77","DOI":"10.1126\/scitranslmed.3005615","article-title":"Increased in vivo amyloid-\u03b242 production, exchange, and loss in presenilin mutation carriers","volume":"5","author":"Potter","year":"2013","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20170425180355_awu367-B44","doi-asserted-by":"crossref","first-page":"1048\u20131056","DOI":"10.1016\/S1474-4422(12)70228-4","article-title":"Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study","volume":"11","author":"Reiman","year":"2012","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B45","doi-asserted-by":"crossref","first-page":"69\u201373","DOI":"10.1016\/0014-5793(94)00259-2","article-title":"An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease","volume":"344","author":"Schmidt","year":"1994","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t20170425180355_awu367-B46","doi-asserted-by":"crossref","first-page":"229\u201336","DOI":"10.1212\/WNL.0b013e31825fdf18","article-title":"Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers","volume":"79","author":"Sch\u00f6ll","year":"2012","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170425180355_awu367-B47","doi-asserted-by":"crossref","first-page":"403\u201313","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B48","doi-asserted-by":"crossref","first-page":"325\u201333","DOI":"10.1111\/j.1471-4159.2011.07553.x","article-title":"Measurement of Abeta1-42 in cerebrospinal fluid is influenced by matrix effects","volume":"120","author":"Slemmon","year":"2012","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170425180355_awu367-B49","doi-asserted-by":"crossref","first-page":"280\u201392","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"key\n\t\t\t\t20170425180355_awu367-B50","doi-asserted-by":"crossref","first-page":"1464\u201370","DOI":"10.2967\/jnumed.109.064360","article-title":"Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding","volume":"50","author":"Tolboom","year":"2009","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20170425180355_awu367-B51","doi-asserted-by":"crossref","first-page":"659\u201370","DOI":"10.1007\/s00401-013-1151-4","article-title":"Longitudinal change in CSF Tau and A\u03b2 biomarkers for up to 48 months in ADNI","volume":"126","author":"Toledo","year":"2013","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B52","doi-asserted-by":"crossref","first-page":"241\u201352","DOI":"10.1016\/S1474-4422(10)70325-2","article-title":"Apolipoprotein E in Alzheimer's disease and other neurological disorders","volume":"10","author":"Verghese","year":"2011","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B53","doi-asserted-by":"crossref","first-page":"357\u201367","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B54","doi-asserted-by":"crossref","first-page":"133\u201341","DOI":"10.1016\/j.jalz.2010.08.230","article-title":"Transforming CSF A?42 measures into calculated Pittsburgh Compound B (PIBcalc) units of brain A? amyloid","volume":"7","author":"Weigand","year":"2011","journal-title":"Alzheimers Dement"},{"key":"key\n\t\t\t\t20170425180355_awu367-B55","doi-asserted-by":"crossref","first-page":"1053\u20139","DOI":"10.1111\/j.1471-4159.2006.04404.x","article-title":"Amyloid beta peptide ratio 42\/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load","volume":"101","author":"Wiltfang","year":"2007","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170425180355_awu367-B56","first-page":"593\u20137","article-title":"Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain","volume":"135","author":"Yamaguchi","year":"1989","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170425180355_awu367-B57","doi-asserted-by":"crossref","first-page":"801\u20137","DOI":"10.3233\/JAD-132561","article-title":"Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort","volume":"41","author":"Zwan","year":"2014","journal-title":"J Alzheimers Dis"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/138\/3\/772\/13798965\/awu367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:51:32Z","timestamp":1566175892000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awu367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,24]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,12,24]]},"published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awu367","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,24]]}}}